Clinical Trial Update: IgM-Enriched Immunoglobulin for Neonatal Sepsis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating IgM-enriched immunoglobulin for neonatal sepsis (early-onset) in very low birth weight infants; status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Early-onset Neonatal Sepsis
• Infant Newborn Disease
• Neonatal Sepsis
• Very Low Birth Weight Infant Complication

Drugs mentioned

• IgM-enriched immunoglobulin (IgM-enriched immunoglobulin)

Snippet

Sponsor: Fakultas Kedokteran Universitas Indonesia | Conditions: Neonatal Sepsis, Early-Onset, Very Low Birth Weight Infant | Phase 3 | Status: UNKNOWN